相似文献
1
Characterization of pharmacogenetic variation in African populations and comparison with other global populations.非洲人群的药物遗传学变异特征及其与其他全球人群的比较。
Pharmacogenomics. 2023 Nov;24(16):845-857. doi: 10.2217/pgs-2023-0166. Epub 2023 Nov 6.
2
Characterization of haplotype distribution in African populations and comparison with other global populations.分析非洲人群的单体型分布特征，并与其他全球人群进行比较。
Pharmacogenomics. 2022 Sep;23(14):771-782. doi: 10.2217/pgs-2022-0082. Epub 2022 Aug 31.
3
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations.撒哈拉以南非洲人群 CYP2B6 和 CYP2A6 遗传药理学变异的特征。
Clin Pharmacol Ther. 2024 Mar;115(3):576-594. doi: 10.1002/cpt.3124. Epub 2023 Dec 20.
4
PharmVar GeneFocus: CYP2C19.药物代谢基因变异数据库重点关注 CYP2C19 基因。
Clin Pharmacol Ther. 2021 Feb;109(2):352-366. doi: 10.1002/cpt.1973. Epub 2020 Jul 22.
5
StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes.StellarPGx：用于在细胞色素 P450 基因中调用星等位基因的 Nextflow 管道。
Clin Pharmacol Ther. 2021 Sep;110(3):741-749. doi: 10.1002/cpt.2173. Epub 2021 Feb 28.
6
Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program.实施氯吡格雷药物遗传学临床决策支持以实现结果的预先反馈程序。
Am J Health Syst Pharm. 2024 Jun 11;81(12):555-562. doi: 10.1093/ajhp/zxae008.
7
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.精神科商业药物遗传学检测的系统评价：聚焦CYP2D6和CYP2C19等位基因覆盖范围及结果报告
Pharmacogenet Genomics. 2017 Nov;27(11):387-393. doi: 10.1097/FPC.0000000000000303.
8
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.CYP2C19基因分型对经皮冠状动脉介入治疗后以及接受氯吡格雷治疗的亚洲人群的不良心血管结局影响更大：一项荟萃分析。
Circ Cardiovasc Genet. 2014 Dec;7(6):895-902. doi: 10.1161/CIRCGENETICS.114.000669. Epub 2014 Sep 25.
9
Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients.在巴基斯坦患者中，氯吡格雷的抗血小板反应与 CYP2C19 基因中的单倍型相关。
Sci Rep. 2022 Apr 13;12(1):6171. doi: 10.1038/s41598-022-09679-8.
10
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.CYP2C19*17 等位基因对经皮冠状动脉介入治疗后接受基于基因型的抗血小板治疗患者结局的影响。
Clin Pharmacol Ther. 2021 Mar;109(3):705-715. doi: 10.1002/cpt.2039. Epub 2020 Oct 2.
引用本文的文献
1
The Frequency of Gene Polymorphisms in Burkina Faso Patients Treated with Clopidogrel.布基纳法索接受氯吡格雷治疗患者的基因多态性频率
Appl Clin Genet. 2025 May 1;18:55-61. doi: 10.2147/TACG.S509095. eCollection 2025.
本文引用的文献
1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.一个 12 基因药物遗传学检测面板以预防药物不良反应：一项开放标签、多中心、对照、集群随机交叉实施研究。
Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4.
2
An efficient genotyper and star-allele caller for pharmacogenomics.一种高效的药物基因组学基因分型和星等位基因 caller。
Genome Res. 2023 Jan;33(1):61-70. doi: 10.1101/gr.277075.122. Epub 2023 Jan 19.
3
Promoting Pharmacogenomics in Africa: Perspectives From Variation in G6PD and Other Pharmacogenes.促进非洲的药物基因组学：葡萄糖-6-磷酸脱氢酶及其他药物基因变异的视角
Clin Pharmacol Ther. 2023 Mar;113(3):476-479. doi: 10.1002/cpt.2816. Epub 2022 Dec 28.
4
High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios.对扩展的 1000 基因组项目队列进行高覆盖率全基因组测序，包括 602 个三核苷酸重复序列。
Cell. 2022 Sep 1;185(18):3426-3440.e19. doi: 10.1016/j.cell.2022.08.004.
5
Individualized Medicine in Africa: Bringing the Practice Into the Realms of Population Heterogeneity.非洲的个性化医疗：将实践带入人群异质性领域。
Front Genet. 2022 Apr 14;13:853969. doi: 10.3389/fgene.2022.853969. eCollection 2022.
6
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.临床药物遗传学实施联盟 CYP2C19 基因型和氯吡格雷治疗指南：2022 更新版。
Clin Pharmacol Ther. 2022 Nov;112(5):959-967. doi: 10.1002/cpt.2526. Epub 2022 Feb 8.
7
Cytochrome P450 Enzymes and Drug Metabolism in Humans.细胞色素 P450 酶与人体药物代谢。
Int J Mol Sci. 2021 Nov 26;22(23):12808. doi: 10.3390/ijms222312808.
8
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations.撒哈拉以南非洲人群中药物代谢动力学（ADME）基因变异的程度及影响
Front Pharmacol. 2021 Apr 28;12:634016. doi: 10.3389/fphar.2021.634016. eCollection 2021.
9
Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm.华法林药代动力学相关遗传变异分析：黑种人表现出独特的遗传标记，这些标记对非洲特有的华法林药物基因组学剂量算法非常重要。
J Thromb Haemost. 2021 Dec;19(12):2957-2973. doi: 10.1111/jth.15494. Epub 2021 Sep 29.
10
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.基于证据的个体化医学中评估药物基因组学知识的框架。
Clin Pharmacol Ther. 2021 Sep;110(3):563-572. doi: 10.1002/cpt.2350. Epub 2021 Jul 22.
Zotero 插件